ATE479439T1 - Parvovirus mit cpg-angereichertem genom zur krebstherapie - Google Patents

Parvovirus mit cpg-angereichertem genom zur krebstherapie

Info

Publication number
ATE479439T1
ATE479439T1 AT07025215T AT07025215T ATE479439T1 AT E479439 T1 ATE479439 T1 AT E479439T1 AT 07025215 T AT07025215 T AT 07025215T AT 07025215 T AT07025215 T AT 07025215T AT E479439 T1 ATE479439 T1 AT E479439T1
Authority
AT
Austria
Prior art keywords
parvovirus
cpg
genome
rat
cancer therapy
Prior art date
Application number
AT07025215T
Other languages
English (en)
Inventor
Zahari Raykov
Jean Rommelaere
Nathalia Giese
Marc Aprahamian
Original Assignee
Deutsches Krebsforsch
Univ Ruprecht Karls Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Univ Ruprecht Karls Heidelberg filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE479439T1 publication Critical patent/ATE479439T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT07025215T 2007-12-28 2007-12-28 Parvovirus mit cpg-angereichertem genom zur krebstherapie ATE479439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07025215A EP2075003B1 (de) 2007-12-28 2007-12-28 Parvovirus mit CpG-angereichertem Genom zur Krebstherapie

Publications (1)

Publication Number Publication Date
ATE479439T1 true ATE479439T1 (de) 2010-09-15

Family

ID=39325477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07025215T ATE479439T1 (de) 2007-12-28 2007-12-28 Parvovirus mit cpg-angereichertem genom zur krebstherapie

Country Status (8)

Country Link
US (2) US8535929B2 (de)
EP (1) EP2075003B1 (de)
JP (1) JP4934221B2 (de)
AT (1) ATE479439T1 (de)
CA (1) CA2710889C (de)
DE (1) DE602007008929D1 (de)
ES (1) ES2352534T3 (de)
WO (1) WO2009083202A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266587A1 (de) * 2009-06-04 2010-12-29 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Onkolytische Virotherapie zur Vorbeugung von Tumorrezidiv
US9056070B2 (en) 2010-04-27 2015-06-16 Universidad Manuela Beltran Autologous biological cancer vaccine
AU2011317846B2 (en) * 2010-10-21 2015-07-09 Deutsches Krebsforschungszentrum Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid
US20130129678A1 (en) 2011-11-17 2013-05-23 Zahari Raykov Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
AU2016397532A1 (en) * 2016-03-17 2018-08-23 Deutsches Krebsforschungszentrum Lung cancer therapy with a parvovirus
US11562141B2 (en) * 2017-07-18 2023-01-24 Koninklijke Philips N.V. Mapping of coded medical vocabularies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4117027B2 (ja) * 1996-04-19 2008-07-09 コルパン メチン パルボウイルス感染のための核酸予防接種
EP1003531B1 (de) * 1997-05-20 2007-08-22 Ottawa Health Research Institute Verfahren zur Herstellung von Nukleinsäurekonstrukten
US7179456B2 (en) * 2003-04-30 2007-02-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Use of parvovirus for brain tumor therapy

Also Published As

Publication number Publication date
EP2075003A1 (de) 2009-07-01
EP2075003B1 (de) 2010-09-01
JP2011507535A (ja) 2011-03-10
US10098917B2 (en) 2018-10-16
WO2009083202A1 (en) 2009-07-09
US8535929B2 (en) 2013-09-17
CA2710889C (en) 2015-08-04
US20110033425A1 (en) 2011-02-10
JP4934221B2 (ja) 2012-05-16
US20130344034A1 (en) 2013-12-26
ES2352534T3 (es) 2011-02-21
DE602007008929D1 (de) 2010-10-14
CA2710889A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
DK2431045T3 (da) Bugspytkirtelkræftterapi med en parvovirus
ATE479439T1 (de) Parvovirus mit cpg-angereichertem genom zur krebstherapie
Larsson Re-thinking the classification of corticioid fungi
Takahashi et al. Full or near full length nucleotide sequences of TT virus variants (types SANBAN and YONBAN) and the TT virus-like mini virus
WO2011015656A3 (en) Composition for treating hbv infection
MX2009009473A (es) Compuestos para el tratamiento de hepatitis c.
WO2008118507A3 (en) Recombinant human factor ix and use thereof
WO2005042728A3 (en) Immortalized avian cell lines for virus production
DE602005027621D1 (de) Verwendung einer Nukleinsäure zur Herstellung einer transgenen Pflanze mit verbesserter Toleranz gegenüber Trockenheit
DK1554301T3 (da) Dengue-vaccine med en fælles udeladelse af 30 nukleotider i Dengue-typerne 1's og 2's3'UTR
TW200745120A (en) Indolobenzazepine HCV NS5B inhibitors
WO2006104945A3 (en) Hepatitis c therapies
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
Lauck et al. Historical outbreaks of simian hemorrhagic fever in captive macaques were caused by distinct arteriviruses
WO2010047830A3 (en) Agents for hcv treatment
ATE494291T1 (de) Verbindungen zur behandlung von hepatitis c
MX2010001416A (es) Compuesto para el tratamiento de la hepatitis c.
Sakuda et al. Oncolytic effect of a recombinant vesicular stomatitis virus encoding a tumor-suppressor microRNA in an osteosarcoma mouse model
Masolini Public Authority and Right to Kill in the ‘Petit’and ‘Falkenberg Affairs’ at the Council of Constance (1414–1418)
BR0308736A (pt) Células de pulmão de rato cotton para cultura de vìrus
Jeoung et al. Complete genome sequences of classical swine fever virus strains isolated from wild boars in South Korea
WO2006047301A3 (en) Parvovirus methods and compositions for killing neoplastic cells
Li et al. Genome sequence of a highly prevalent porcine partetravirus in mainland China
Sarkar et al. RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus
Shi et al. Characterization of a Pestivirus H isolate originating from goats

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2075003

Country of ref document: EP